CAS: 537672-41-6
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | 4-bromo-N'-butylbenzohydrazide REF: IN-DA00DB9ECAS: 537672-41-6 | 96% | To inquire | Fri 07 Feb 25 |
 | UF010 REF: TM-T3205CAS: 537672-41-6 | 98.03% - 98.11% | 35.00 €~160.00 € | Fri 14 Feb 25 |
 | UF010 REF: 3D-MWA67241CAS: 537672-41-6 | Min. 95% | - - - | Discontinued product |
4-bromo-N'-butylbenzohydrazide
CAS:537672-41-6
Formula:
C11H15BrN2O
Purity:
96%
Color and Shape:
Solid
Molecular weight:
271.1536
Ref: IN-DA00DB9E
| 1g | To inquire | ||
| 5mg | 81.00 € | ||
| 10mg | 119.00 € | ||
| 25mg | 152.00 € | ||
| 50mg | 241.00 € | ||
| 100mg | 510.00 € | ||
| 250mg | 629.00 € |
Estimated delivery in United States, on Friday 7 Feb 2025
UF010
CAS:537672-41-6
UF010 is a potent and selective HADC inhibitor with IC50 ~0.06 μM, 0.1 μM, 0.5 …
Formula:
C11H15BrN2O
Purity:
98.03% - 98.11%
Color and Shape:
Solid
Molecular weight:
271.15
Ref: TM-T3205
| 25mg | 52.00 € | ||
| 50mg | 75.00 € | ||
| 100mg | 106.00 € | ||
| 200mg | 160.00 € |
Estimated delivery in United States, on Friday 14 Feb 2025
UF010
CAS:537672-41-6
UF010 is a potential cancer therapy that has been shown to induce dedifferentiation of cancer …
Formula:
C11H15BrN2O
Purity:
Min. 95%
Molecular weight:
271.15 g/mol
Ref: 3D-MWA67241
| 5mg | Discontinued | Request information | |
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information | |
| 100mg | Discontinued | Request information |
